Amsterdam, the Netherlands and Vienna, Austria – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced new OB/GYN innovations, aBiometry AssistA.I, TouchVue and Tilt , as well as the eL18-4 transducer  available on Philips EPIQ 7 and 5 and Affiniti 70 ultrasound systems. Showcased at the 27th World Congress on Ultrasound in Obstetrics and Gynecology (ISUOG), Philips’ OB/GYN ultrasound solutions are designed to give clinicians more information earlier in pregnancy, making it easier to provide a confident diagnosis and overcome diagnostic challenges. They feature innovations such as anatomical intelligence, fingertip control and enhanced imaging versatility. Philips will also debut its new InnoSight touch-screen based diagnostic compact ultrasound, which offers exceptional image quality and performance.
“At Philips, we are committed to meeting the unique and growing needs of OB/GYNs and their patients through innovation,” said Vitor Rocha, Business Leader Ultrasound at Philips. “Deeper levels of definition and clarity enable early, evidence-based decisions, and our solutions with ergonomic tools help to further optimize workflow to provide clinicians more time with patients. Our ultrasound solutions are designed for life, giving clinicians diagnostic confidence and their patients’ peace of mind.”
“Philips' latest OB/GYN ultrasound offerings provide clinicians with the tools to deliver diagnostic confidence needed to deliver the best care for patients,” said Dr. Michael Ruma, maternal-fetal medicine specialist at Perinatal Associates of New Mexico. “The beginning of a new life is a special time, and Philips’ solutions allow clinicians to focus on the needs of each expecting mother.”